Obesity is an increasingly serious health problem in the world. Body mass index (BMI), percentage fat mass, and body fat mass are important indices of obesity. For a sample of pedigrees that contains 110,000 relative pairs (including 1,249 sib pairs) that are useful for linkage analyses, we performed a whole-genome linkage scan, using 380 microsatellite markers to identify genomic regions that may contain quantitative-trait loci (QTLs) for obesity. Each pedigree was ascertained through a proband who has extremely low bone mass, which translates into a low BMI. A major QTL for BMI was identified on 2q14 near the marker D2S347 with a LOD score of 4.04 in twopoint analysis and a maximum LOD score (MLS) of 4.44 in multipoint analysis. The genomic region near 2q14 also achieved an MLS 12.0 for percentage of fat mass and body fat mass. For the putative QTL on 2q14, as much as 28.2% of BMI variation (after adjustment for age and sex) may be attributable to this locus. In addition, several other genomic regions that may contain obesity-related QTLs are suggested. For example, 1p36 near the marker D1S468 may contain a QTL for BMI variation, with a LOD score of 2.75 in two-point analysis and an MLS of 2.09 in multipoint analysis. The genomic regions identified in this and earlier reports are compared for further exploration in extension studies that use larger samples and/or denser markers for confirmation and fine-mapping studies, to eventually identify major functional genes involved in obesity.
Introduction
Obesity is a disease condition with excess body fat that adversely affects health (Kopelman 2000) . Obesity is associated with many diseases, such as type 2 diabetes mellitus, hypertension, coronary heart disease, and some cancers (Must et al. 1999; Kopelman 2000) . A higher BMI (an important measure of obesity that expresses the ratio of weight to the square of height in kilograms per square meter) is associated with higher mortality (Calle et al. 1999) . About 250 million adults (7% of the world adult population) are considered obese (defined as having a BMI 130 kg/m 2 ), and two or three times as many may be considered overweight (defined as having a BMI of 25-30 kg/m 2 ) (Kuczmarski et al. 1994; Seidell 1999 ). In the United States, 59.4% of men and 50.7% of women are overweight or obese (Flegal et al. 1998 ). The direct costs associated with obesity are estimated to be ∼$100 billion per year, which represents 5.7% of the national health expenditure in the United States in 1995 (Wolf and Colditz 1998) . A more recent analysis shows that the health care cost of obesity in the United States is most likely between 0.89% and 4.32% (Allison et al. 1999b ).
Obesity is a complex trait that is determined by multiple genetic and environmental factors (including physiological, behavioral, and sociocultural factors) (Comuzzie and Allison 1998; Echwald 1999; Pérusse and Bouchard 1999) . Numerous studies have been conducted to characterize the heritability of obesity-related phenotypes. Most studies are based on BMI, but a few are based on fat mass and percentage fat mass (PFM) and a few on lean mass. The estimates of heritability (h 2 ) of BMI ranged from 0.05 to 0.90 (Stunkard et al. 1986 (Stunkard et al. , 1990 Bouchard et al. 1988; Selby et al. 1991; Harris et al. 1995; Vogler et al. 1995; Allison et al. 1996; Borecki et al. 1998; Rice et al. 1999) . For fat mass, h 2 estimates range from 20% to 65% (Bouchard et al. 1988; Comuzzie et al. 1995 Comuzzie et al. , 1997 Rice et al. 1997a; Samaras et al. 1997; Nguyen et al. 1998 ). For PFM, h 2 estimates are 62%-80% (Rice et al. 1997b; Sakurai et al. 1997; Faith et al. 1999) . In h 2 studies of fat mass and PFM, few have employed measurement by dual energy x-ray absorptiometry (DXA) (but see Samaras et al. 1997 and Nguyen et al. 1998) , largely because of the relatively recent availability of DXA and its associated relatively large expenses for the measurement. For lean mass, h 2 estimates are 0.52%-0.80% (Forbes et al. 1995; Arden and Spector 1997; Nguyen et al. 1998) . In our study sample, after adjustment for age, sex, and life style factors, h 2 , estimates of BMI, fat mass, PFM, and lean mass (the latter three phenotypes measured by DXA) are 0.52%-0.57% (Deng et al. 2001a) .
The number and the identity of the genes underlying the susceptibility to obesity have received extensive study (Comuzzie and Allison 1998; Echwald 1999; Pérusse and Bouchard 1999) . For the common variation of obesity phenotypes, segregation analyses in several populations suggest that major genes with recessive effects may account for 35%-45% of the variation in obesity-related phenotypes (e.g., BMI, fat mass, and PFM), after adjustment for sex and age (Moll et al. 1991; Rice et al. 1993; Comuzzie et al. 1995) . Other segregation analyses did not reveal any major gene effect but inferred the existence of multiple genes, each with minor effects (Lecomte et al. 1997; Borecki et al. 1998) . A number of candidate genes have been tested by association and/or linkage for obesity phenotypes (Deng et al. 2000b; Pérusse et al 2001) . Genomewide linkage studies have been conducted, and several genomic regions have been reported that may harbor obesity-susceptibility genes (Comuzzie et al. 1997; Hager et al. 1998; Hanson et al. 1998; Norman et al. 1998; Lee et al. 1999; Mitchell et al. 1999; Walder et al. 2000; Watanabe et al. 2000; Hsueh et al. 2001; Feitosa et al. 2002) . The genomic regions identified so far seem to be largely unconfirmed (Pérusse et al. 2001) , except in a few cases (e.g., a QTL for serum leptin concentration on 2p21 [Comuzzie et al. 1997; Hager et al. 1998 ] and a locus for obesity on 10p [Hager et al. 1998; Hinney et al. 2000] ). Hence, further gene-mapping studies in various samples and populations are warranted. Only by comparing different studies of various population samples and by disentangling biological and statistical causes that underlie the consistent results-as well as the inconsistent ones-may we eventually identify major QTLs for obesity.
In the present study, we genotyped 380 highly heterozygous markers across the whole genome for each of the 630 subjects, who are members of 53 white pedigrees that contain 110,000 relative pairs (including 1,249 sib pairs) that are useful for linkage analyses. We performed a whole-genome linkage scan to identify genomic regions that are potentially important for obesity phenotypes. The study identified a major QTL for BMI and several other genomic regions of potential importance for BMI, fat mass, PFM, and lean mass, and it provides a basis for further extension and confirmation studies for these putative genomic regions and for close examination of the candidate genes identified inside these genomic regions in the present study population.
Subjects and Methods

Subjects
The study was approved by the Creighton University institutional review board. All the study subjects signed informed-consent documents before entering the project. The study subjects came from an expanding database that is being created for studies to search for genes underlying the risk of osteoporosis and obesity that is underway in the Osteoporosis Research Center of Creighton University. Only healthy people (defined by the exclusion criteria that are detailed below) were included in the analysis. All the study subjects were white individuals of European origin, and 53 pedigrees with 630 subjects (248 males and 382 females) from 2-4 generations were analyzed. The pedigrees range from 3 to 99 individuals, with a mean (SE) of 11.7 (2.4). Each pedigree was identified through a proband having bone mineral density (BMD) Z scores less than Ϫ1.28 at the hip or spine. BMD values expressed as Z scores adjust for age, sex, and ethnic difference in healthy referent populations. Hence, to identify QTLs for BMD (Deng et al. 2001b) , we selected the probands from the lowest 10% of the population BMD variation for the purpose of achieving higher statistical power than would be achieved through random sampling (Risch and Zhang 1995; Deng and Li, in press) . Because BMD and BMI are significantly correlated (Deng et al. 2000a) , the sampling scheme of our study pedigrees for enhancing the power of linkage analysis to detect genomic regions for BMD variation may also have a similar effect (if any) on BMI and related obesity phenotypes. In fact, the probands tend to have BMI that are lower than the average in their pedigrees (see "Results" section).
The exclusion criteria for the study subjects were a history of (1) serious residual effects of cerebral vascular disease; (2) diabetes mellitus, except for easily controlled, non-insulin-dependent diabetes mellitus (defined as adult asymptomatic hyperglycemia controlled by diet or oral agents); (3) chronic renal disease manifested by serum creatinine 11.9 mg/dl; (4) chronic liver disease or alcoholism; (5) significant chronic lung disease; (6) 16 mo of corticosteroid therapy at pharmacologic levels; (7) 16 mo of treatment with anticonvulsant therapy; (8) evidence of other metabolic or inherited bone disease, such as hyper-or hypoparathyroidism, Paget disease, osteomalacia, or osteogenesis imperfecta; (9) rheumatoid arthritis or collagen disease; (10) recent (within the past year) major gastrointestinal disease, such as peptic ulcer, malabsorption, chronic ulcerative colitis, regional enteritis, or any significant chronic diarrhea state; (11) significant disease of any endocrine organ that would affect bone mass; (12) hyperthyroidism; (13) any neurologic or musculoskeletal condition that would be a nongenetic cause of low bone mass; and (14) any disease, treatment, or condition that would be a nongenetic cause of low bone mass. The exclusion criteria were assessed by nurse-administered questionnaires and/or examination of medical records and were applied most rigorously to potential subjects contacted between the ages of 25 and 50 years. About 5.1% of the total people screened were excluded from our study sample because they met at least one of the exclusion criteria. The exclusion criteria applied might render the allele frequencies and thus the genetic effects of potential obesity QTLs different from those in our general population. This may be the case when some of the above disease states are genetically correlated with obesity, for which there is generally no evidence at present.
Genotyping
For each subject, blood (20 cc) was drawn into EDTAcontaining tubes by certified phlebotomists and was stored chilled (∼4ЊC) until DNA extraction, which was usually completed within the next five calendar days. DNA was extracted by employing a kit (Gentra Systems), according to the procedures detailed in the manufacturer's instructions. DNA was genotyped using fluorescently labeled markers, as we did before (Deng et al. 2000c ). The 400 dinucleotide markers with which we started our genotyping are commercially available through Perkin-Elmer Applied Biosystems (ABI Prism Linkage Mapping Sets, version 2). The PCR was performed on PE 9700 thermocyclers (Applied Biosystems). PCR cycling conditions followed those suggested in the ABI Prism Linkage Mapping Sets, version 2. Genotyping was performed using Applied Biosystems automated DNA sequencing systems (models 377 and 310) running the Genescan and Genotyper softwares for allele identification and sizing. A genetic database management system (GenoDB) developed by us (Li et al. 2001 ) was employed to manage the phenotype and genotype data for linkage analyses. GenoDB is also employed for allele binning (including setting up allele-binning criteria and converting allele sizes to distinct allele numbers), quality control, and formatting of data for PedCheck (O'Connell and Weeks 1998) and for linkage analyses by SOLAR. PedCheck was employed for checking the conformation to Mendelian inheritance patterns at all the marker loci and for checking the relationships of family members within pedigrees. The genotyping error rate, determined by at least three rounds of sample replication in experiments and data analyses by PedCheck, was ∼0.3%. Of the markers, 380 (including 362 on autosomes) were successfully genotyped. These markers have an average population heterozygosity of ∼0.79 and are spaced an average of ∼8.6 cM from adjacent markers throughout the human genome.
Measurement
Fat mass and lean mass were measured by DXA with a Hologic 2000ϩ or 4500 scanner. Measurements of BMD on the two types of machines agreed within 1%, but the body mass measurements differed in an unsystematic way. For 24 people who underwent scans on the same day on the two types of machines, the difference in whole body mass is ∼3%. All machines were calibrated daily. The body-composition bar was used on every whole-body scan on the Hologic 2000ϩ. On the Hologic 4500, the bar was not needed for the body scans; instead, it was scanned every week. In the early stage of the study, the subjects were recruited for studying osteoporosis only. Thus, we did not install the hardware and software to perform the body composition assessment until later in the recruitment for the project. Therefore, we have data on fat mass, PFM, and lean mass for only 289 subjects from 38 pedigrees. Software and hardware have been kept up to date throughout the implementation of the project. For the Hologic 2000ϩ scanner that was in service during 1994-1999, the software was updated from version 5.67a to version 5.71a. For the Hologic 4500 scanner that has been in service since 1997, the software has been updated from version 8.19a to version 8.26a. The PFM is the ratio of fat mass divided by body weight (i.e., the sum of fat mass plus lean mass plus bone mineral content). The measurement precision of BMI as reflected by coefficient of variation was 0.2%. The coefficients of variation for fat mass, PFM, and lean mass were 2.2%, 2.2%, and 1.0%, respectively, for measurements obtained on the Hologic 2000ϩ, and were 1.2%, 1.1%, and 0.7%, respectively, for measurements obtained on the Hologic 4500. Members of the same pedigree were usually measured on the same type of machine.
Statistical Analyses
A variance-component linkage analysis (Amos 1994; Amos et al. 1996; Almasy and Blangero 1998) for quantitative traits was performed. The analysis is based on specifying the expected genetic covariances between relatives as a function of the identity by descent at a given marker locus. The analysis considers the phenotypic and genetic information from all pedigree members simultaneously. The analysis assumed joint multivariate normality of phenotypic values, additive genetic effects, and no interaction between genes and the residual. The program employed was SOLAR (Sequential Oligogenic Linkage Analysis Routines) , which is available on the Internet. The pedigree-ascertainment scheme based on the low BMD values of probands leads to lower-than-average BMI values (see "Results"). The ascertainment scheme was accounted for in the analyses by identifying to the program the probands and their phenotypic values for each pedigree. The built-in modules of the SOLAR program will then be able to account for the ascertainment scheme by using conditional likelihoods in LOD score computation. The statistical properties of the variance-component analyses after the ascertainment correction have been preliminarily investigated (de Andrade et al. 1997; de Andrade and Amos 2000; Sham 2000) .
In linkage analysis, age and sex were adjusted as covariates for the obesity phenotypic values, because these generally affect the variation of obesity phenotypes significantly in our study population (Deng et al. 2000b ). Analyses were also performed without adjusting for one or both of these covariates. Adjustment for significant covariates in genetic analyses can generally increase the genetic signal-to-noise ratio in linkage detection by decreasing the proportion of the residual phenotypic variation attributable to random environmental factors (Deng et al. 1999 ). This may thus improve statistical power in our linkage analyses. Comparison of the analyses with and without adjustment for a significant covariate may shed light on the genomic regions identified regarding their direct importance for the trait per se or indirect importance via the influence on the covariate only. The variance-component analyses implemented in SOLAR are generally robust to violations of normality of the data (Williams et al. 1999 ). However, some types of nonnormality of the data may inflate the type I error rate in excess of specified nominal levels (Allison et al. 1999a) . The phenotype data were tested by graphical methods (Sokal and Rohlf 1995) and found not to deviate from normal distributions. Marker-allele frequencies were obtained by maximum likelihood estimation in SOLAR. Hypothesis testing for linkage was conducted by the maximum-likelihood method by investigating the relationship of genetic covariances and the identity-bydescent between relatives. The method compares the maximum likelihoods obtained in the full model (which shows linkage so the locus is a QTL and accounts for some additive genetic variance) with the nested null model (which does not show linkage so the locus is not a QTL). The difference between the two log 10 likelihoods yields a LOD score. Twice the difference of the log e of the likelihoods of these two models is asymptotically distributed as a : mixture of a x 2 variable and a point 1 1 2 2 mass at 0 (Almasy and Blangero 1998) with 1 df. Using SOLAR, we performed two-point and multipoint linkage analyses, respectively, for the obesity phenotypes. LOD scores may be converted to approximate P values (prior to accounting for multiple testing), which is commonly employed in statistical testing through a x 2 distribution (Lander and Kruglyak 1995) . When a putative QTL is suggested, the proportion of phenotypic variation attributable to this QTL can be estimated by SO-LAR. The estimate is usually an upper bound of the genetic effect due to the locus (Gö ring et al 2001).
Results
The basic characteristics of the study subjects, stratified by age and sex, are summarized in Appendix A (table  3) . Some information about the family structure of the study pedigrees is summarized in Appendix B (table 4) . Appendix B shows that, for the analyses for BMI, there are 110,000 informative relative pairs (including 1,249 sibling pairs, 1,098 grandparent-grandchild pairs, 1,993 avuncular pairs, and 2,589 first-cousin pairs). For the analyses for fat mass, lean mass and PFM, there are nearly 6,000 informative relative pairs (including 744 sibling pairs, 710 grandparent-grandchild pairs, 1,148 avuncular pairs, and 1,500 first-cousin pairs). These large numbers of informative relative pairs reflect the richness of the genetic information for linkage analyses in our sample. The correlations between BMI and spine and hip BMD are, respectively, 0.27 and 0.44, both significant at . In our sample, the mean (SE) of BMI, P ! .01 adjusted for age and sex, is 26.45 (0.21) for all the subjects and is 23.97 (0.63) for probands. The BMI value is significantly smaller ( ) in the probands, reflect-P ! .01 ing our sampling scheme through low BMD values.
The results for the chromosomes that had a maximum LOD score 12.0 in multipoint linkage analyses for any one of the four obesity phenotypes are summarized in figure 1 , the results for the other chromosomes are summarized in figure 2. Because the current version of SO-LAR does not handle multipoint linkage analyses for the X chromosome, to convey the linkage signal pattern on the X chromosome, we plotted two-point LOD score results for the X chromosome ( fig. 2) . For the analysis results presented, obesity phenotypes were adjusted, by use of multiple regression, for significant covariates of age and sex. The results (not shown) of the linkage analyses for obesity phenotypes that were not adjusted for covariates showed a similar pattern in LOD scores and qualitatively the same results, suggesting that any impact of the genomic regions identified here produces a direct effect on obesity phenotypes rather than influencing phenotypes through a covariate.
Notably ( fig. 1 and tables 1 and 2) , for BMI, a major QTL on 2q14 is identified with a maximum LOD score (MLS) of 4.44 ( ) at 128 cM from pter on P p .000003 chromosome 2 in multipoint linkage analyses. In twopoint linkage analyses, a LOD score of 4.04 (P p ) is achieved at the marker D2S347 on 2q14. .000008 For this putative major QTL for BMI, as much as 28.2% of BMI variation (after adjustment for age and sex) may be attributable to this locus. In addition, the importance of this genomic region is manifested for PFM and body fat mass. For PFM, 2q14 may contain a QTL with an MLS of 2.10 ( ) at 128 cM from pter on P p .00093 chromosome 2 in multipoint analyses, and a LOD score of 1.91 ( ) is achieved at the marker D2S347 P p .0015
Figure 1
Multipoint linkage analysis results for the chromosomes that had an MLS 12.0. Results are shown for BMI (black), PFM (green), fat mass (red), and lean mass (blue). on 2q14 in two-point analyses. For body fat mass, 2q14 achieved an MLS of 2.21 ( ) at 128 cM from P p .0007 pter on chromosome 2 in multipoint analyses, and in two-point analyses, a LOD score of 2.03 ( ) P p .0011 is achieved at D2S347 on 2q14.
In addition to the genomic region 2q14, a few other genomic regions were identified that had LOD scores 11.5 and that may harbor QTLs for the obesity phenotypes under study ( fig. 1 and table 1 ). For BMI, four additional genomic regions were suggested. Region 1p36 may contain a QTL with an MLS of 2.09 (P p ) at the terminal end of short arm on chromo-.00095 some 1 in multipoint analyses. In two-point analyses, a LOD score of 2.75 ( ) is achieved at D1S468 P p .00019 on 1p36. Region 4q12 may contain a QTL with an MLS of 2.09 ( ) at 68 cM from pter on chro-P p .00096 mosome 4 in multipoint analyses. In two-point analyses, a LOD score of 2.29 ( ) is achieved at P p .00058 D4S1592 on 4q12. Two genomic regions with LOD scores 11.50 in either multi-or two-point linkage analyses ( fig. 2; table 1 ) are also noticeable. The genetic signals manifested in these genomic regions may deserve further close examination in extended samples and/or denser molecular markers. These noteworthy genomic regions include 6q27 with an MLS of 1.61 (P p ) in multipoint analyses at 188 cM from pter on .0032 chromosome 6 in multipoint analyses, and those at the marker D6S281 on 6q27 with a LOD score of 1.77 ( ), the marker D2S160 on 2q12 with a LOD P p .0021 score of 2.56 ( ), in two-point analyses. For P p .00030 PFM, in two-point analyses, a LOD score of 1.95 ( ) is achieved at D2S206 on 2q36; 8q24 P p .0014 achieved an MLS of 1.54 ( ) in multipoint P p .0039 analyses.
For fat mass, 6q27 achieved an MLS of 1.59 (P p ) at 188 cM from pter on chromosome 6 in mul-.0034 tipoint analyses. In two-point analyses, a LOD score of 2.02 ( ) is achieved at D6S281 on 6q27. The P p .0011 other noteworthy genomic regions are 20q13, which achieved an MLS of 1.64 ( ) at 69 cM from P p .0030 the pter in multipoint analyses, and the marker D8S549 on 8p22, which achieved a LOD score of 1.95 (P p ) in two-point analyses. .0014
For lean mass, we did not detect any genomic region showing a LOD score 12.0 in multipoint or two-point linkage analyses. Some genomic regions with LOD scores 11.50 are noteworthy. In multipoint analyses, these genomic regions include 12q14 with an MLS of 1.64 ( ) at 82 cM from pter on chromosome P p .0030 12, 17p12 with an MLS of 1.63 ( ) at 33 cM P p .0031 from the pter on chromosome 17, and 7p22 with an MLS of 1.52 ( ) at 5 cM from pter on chro-P p .0041 mosome 7. In two-point analyses, a LOD score of 1.79 ( ) is achieved at D12S83 on 12q14, and a P p .0020 LOD score of 1.59 is achieved at D5S407 on 5q11.
Because the pedigree size varies dramatically (from 3 to 99), we performed additional linkage analyses for the largest pedigree and for the rest of the pedigrees. We found that the evidence from the two independent subsamples generally provide support for each other for the major significant results presented for the combined sample, although the significance is weaker in the subsamples.
Discussion
Various phenotypes have been employed for obesity research. The World Health Organization proposed BMI as a simple measure of obesity. BMI has been used widely, because it can be measured conveniently at low cost for large samples (Comuzzie and Allison 1998) .
Figure 2
Multipoint linkage analysis results for the autosomes that had a maximum LOD score !2.0 and the two-point linkage analysis results for the X chromosome. Results are shown for BMI (black), PFM (green), fat mass (red), and lean mass (blue). Note that the scale of the Y-axis is different from that in figure 1. (Pomp 1997) a Candidate genes for BMI are as follows: PGD is involved in carbohydrate metabolism. Enzyme catalyzes a step in the pentose pathway and oxidizes glucose-6-phosphate into 6-phosphoglucono-lactone (Wilson et al. 1991) . TNFR2 is a polymorphism of the TNFR2 gene, which is associated with obesity, leptin levels, and insulin resistance. (Fernandez-Real et al. 2000) . NR0B2 mutations are related to early-onset mild obesity (Nishigori et al. 2001 ). The candidate genes and their cellular functions (if indicated) in the genomic regions are identified via the human obesity gene map (Pérusse et al. 2001) or Online Mendelian Inheritance in Man. The genetic distances are as indicated by the Marshfield linkage map.
However, BMI cannot distinguish fat mass from lean mass and thus may not always be appropriate (Allison and Saunders 2000) . For example, athletes often have a BMI 125 kg/m 2 , along with only 10%-15% body fat (Allison and Saunders 2000) . Body fat mass and PFM are considered phenotypically more homogeneous than BMI and are more appropriate as phenotypes for obesity research (Lecomte et al. 1997 ). However, because fat mass and PFM cannot be measured easily and inexpensively, they have not been used as widely as BMI. It may also be important to study body lean mass, because excess body weight consists of not only fat mass but also lean mass (Chagnon et al. 2000) .
Our purpose is to identify, through a whole-genome scan and by comparison with earlier studies, genomic regions that may contain QTLs underlying the variation of obesity phenotypes. For a sample of pedigrees that contains 110,000 useful relative pairs, we performed a whole-genome linkage scan, using 380 microsatellite markers (with an average heterozygosity of ∼0.79 and spaced ∼8.6 cM apart throughout the whole human genome). For whole-genome linkage studies, phenotypic characteristics and measurement quality of phenotypes-as reflected by coefficient of variation-are often summarized. However, the quality of genotyping data, an important aspect of whole-genome linkage studies and genetic studies involving genotyping in general (Gordon et al. 2001) , has seldom been reported. The genotyping quality should also be reported, because it affects the assessment of the quality of data and thus the robustness of results in linkage studies (Terwilliger et al. 1990 ). The rate of absent or erroneous genotyping data is estimated to be quite low (0.3%) in our study, a fact that is expected to contribute to the strength of our linkage results.
Our sample was recruited for the purpose of efficiently locating genes that underlie BMD (Deng et al. 2001b) , and BMD and body weight are known to be correlated (Deng et al. 2000a) . Because bone mass is a part of body mass, BMD and BMI may also share some genes underlying their variation, although the significance of the shared genetic determination is unknown and is not revealed by comparison of our results in the present study with those from another of our other studies (H.W.D., G.H.X., Q.Y.H., H.S., H.Y.D., Y.J.L., T.C., J.I.L., H.T.Z., K.M.D., and R.R.R., unpublished data). The ascertainment of our multigeneration pedigrees through probands with extremely low BMD values translates into lower-than-average BMI values of the probands, a practice that may yield improved power if any effect is present (Risch and Zhang 1995; Deng and Li, in press) in our sample. The strategy for identifying genes for obesity is, essentially, to search for genes underlying the variation of obesity phenotypes. The recruitment of pedigrees via probands with low BMI and the use of genetic studies of thinness may yield important and complementary findings to genetic studies of obesity conducted by ascertainment through obese subjects (Bulik and Allison 2001) . The loci identified via the ascertainment of low or high extreme phenotype distribution should all be those important for the variation of obesity phenotypes and thus are important for obesity research. The efficacy of gene identification via ascertainment through probands of extremely low or extremely high phenotypic values has been demonstrated (e.g., Risch and Zhang 1995; Deng and Li, in press ). In our study, the larger sample size for the analyses of BMI yields higher statistical power than that for fat mass, lean mass and PFM. The total sample in our study is in the intermediate range compared with earlier genomewide scan studies for obesity (Comuzzie et al. 1997; Hager et al. 1998; Hanson et al. 1998; Norman et al. 1998; Lee et al. 1999; Mitchell et al. 1999; Walder et al. 2000; Watanabe et al. 2000; Hsueh et al. 2001; Feitosa et al. 2002) . The exact power of each study may depend not only on the total sample size but also on a number of other factors, such as pedigree structure, study design and analyses, genotyping quality and molecular markers employed, specific phenotypes under study, potential population-specific genetic effects of QTLs, phenotype distribution within pedigrees or relative pairs, and ascertainment scheme. It would be interesting, in the future, to compare the linkage results obtained in reference to the relative power under various conditions for various studies involving linkage scans. Several genomic regions that may contain QTLs for the variation of the obesity phenotypes studied were identified. Notably, the genomic region near the marker D2S347 on chromosome 2 may contain a QTL for BMI variation. We estimate that this QTL may explain as much as 28.2% of BMI variation (after adjustment for age and sex). In addition, there are several genomic regions identified for the obesity phenotypes studied with LOD scores 11.5 in two-and/or multipoint linkage analyses. Several of the genomic regions identified/suggested coincide with earlier QTL-mapping studies from animal models and harbor several candidate genes (table  1) . The importance of chromosome 2 has been revealed for serum leptin concentration and/or fat mass (Comuzzie et al. 1997; Hager et al. 1998 ). The exact positions of the peak LOD scores (and thus the QTLs involved) reported by Comuzzie et al. (1997) , Hager et al. (1998) , and ourselves are different on chromosome 2 (∼80 cM apart on the Marshfield linkage map). However, the importance of chromosome 2 in obesity etiology seems to be corroborated by a putative QTL region we identified on this chromosome. Several mouse studies have suggested that genes influencing body weight and fatness may be located on chromosome 2, in regions homologous to human chromosome 2q (Pomp 1997) , which further strengthens the importance of chromosome 2 for obesity. The peak on chromosome 1 (1p36) coincided with the region containing the gene TNFR2 (tumor necrosis factor-a receptor 2), whose polymorphism is associated with obesity, leptin levels, and insulin resistance (Fernandez-Real et al. 2000) . In addition, mutations of NR0B2 (nuclear receptor subfamily 0, group B, member 2) were reported to be associated with early-onset mild obesity (Nishigori et al. 2001) . Several of the other genomic regions identified/ suggested, such as 4q12 and 6q27, coincide with earlier QTL-mapping studies from animal models and several candidate genes are suggested (Keightley et al. 1996; Taylor et al. 1997 ).
On chromosome 20q13, Lee et al. (1999) demonstrated a QTL for BMI and PFM; the LOD scores of BMI, PFM, and fat mass in our pedigrees are, respectively, 0.52 ( ), 0.85 ( ) and 1.64 P p .061 P p .024 ( ) on 20q13. Considering that the strength of P p .003 evidence required for replication of a previously found linkage is different from that in a whole-genome linkage analysis (Lander and Kruglyak 1995) , our results lend support to the finding by Lee et al. (1999) that chromosome 20 may harbor a QTL affecting obesity phenotypes. The chromosome region 20q11-13 contains several putative candidate genes for obesity, as outlined below. Agouti-signaling protein (ASIP), whose gene is located on 20q11-13, is a potent inhibitor of a-melanocyte-stimulating hormone receptors 3 and 4 (MC3R and MC4R) (Fong et al. 1997) , and the lack of functional MC4R leads to obesity in mice (Huszar et al. 1997) . Mutations of agouti gene on 20q11-13 lead to obesity in mice (Miller et al. 1993) . CEBPB (CAAT/ enhancer-binding protein b) is related to adipocyte differentiation and is considered one of the candidate genes (Yeh et al. 1995) . Mutations of GNAS1 (guanine nucleotide-binding protein, alpha stimulating activity polypeptide 1) in 20q11-13 is associated with Albright hereditary oteodystrophy, which is partly characterized by obesity (Gunay-Aygen et al. 1997) .
Our data show that, except for the body lean mass and fat mass, the traits analyzed are generally correlated significantly. The phenotypic correlations are, respectively, 0.83 (between BMI and fat mass), 0.33 (between BMI and lean mass), 0.51 (between BMI and PFM), 0.03 (between fat mass and lean mass), 0.84 (between body fat mass and PFM), and Ϫ0.48 (between body lean mass and PFM). However, a significant and high phenotypic correlation does not necessarily imply a significant and high genetic correlation (Deng et al. 2002) , which indexes the degree of shared genetic determination of two phenotypes. Hence, it is not surprising that, although some loci identified in this study show linkage signal to multiple phenotypes (e.g., 2q14 for BMI, PFM, and body fat mass), other loci identified are somewhat more phenotype specific. The polygenic nature of inheritance (Deng et al. 2001b ) and the different sample sizes for the analyses of BMI and other phenotypes may contribute to some of the different findings for various phenotypes. When multiple correlated phenotypes are employed in analyses, LOD scores need to be judged in consideration of multiple testing. We performed our analyses for individual phenotypes in this study; alternatively, multivariate analyses may be performed . In another report (Deng et al., in press), we used factor scores of the principal component of various bone mass phenotypes in complex segregation analyses. However, when the same strategy of multivariate analyses is employed in our linkage analyses for bone sizes at different skeletal sites, multivariate analysis is less sensitive individual univariate analyses in detecting linkage signals (Q.Y.H., F.H.X., H.S., H.Y.D., T.C., Y.J.L., Y.Z.L., J.L.L., K.M.D., R.R.R., and H.W.D., unpublished data). This may be due to heterogeneity in genetic determination of individual loci to different phenotypes involved, a topic that we wish to pursue elsewhere.
The genomic regions identified in this and earlier studies need to be subject to extension studies with more samples and denser markers for confirmation. Those genomic regions and chromosomes that are crosssupported by several types of study (e.g., linkage analyses in humans, QTL mapping in animal models, and candidate genes identified from molecular and cellular studies) may deserve particular attention in our future endeavors. Once the genomic regions are confirmed, subsequent fine-mapping studies need to be pursued to pinpoint the QTLs to genomic regions !1 cM, for eventual identification of the genes and functional mutations involved in the variation of the obesity phenotypes. The candidate genes identified in genomic regions linked to obesity may be subject to association studies and/or transmission-disequilibrium studies (Spielman et al. 1993; Allison 1997) for confirmation of linkage and association. Efforts from multiple approaches and from various groups for the study of different populations should eventually unravel the QTLs that are important for obesity.
Acknowledgments
Investigators of this work were partially supported by grants from Health Future Foundation, National Institutes of Health grants K01 AR02170-01, R01 AR45349-01, R01 GM60402-01A1, P01 DC01813-07), State of Nebraska Cancer and Smoking Related Disease Research Program grant LB 595, State of Nebraska Tobacco Settlement Fund grant LB692, US Department of Energy grant DE-FG03-00ER63000/A00, Creighton University, grants from National Science Foundation of China, and grants from Hunan Normal University and the Ministry of Education of China. We thank Hai-Tao Zhang, Jian Li, Xuan Zhang, Dong-Bon Lai, Xu-Tao Deng, and Yan Zhou for their extensive genotyping effort for this project. Assistance in DNA extraction by the technicians of the Osteoporosis Research Center of Creighton University is appreciated. We thank two anonymous reviewers for their constructive comments that helped to improve the manuscript. 
Appendix A
